28 completed, 5 terminated, 3 unknown, 3 withdrawn. 18 Phase 4, 7 Phase 3, 6 Phase 2, 4 Phase 1, 3 Not applicable.
Follow Paliperidone: new trials by email Literature Review of Paliperidone trials Research Report on Paliperidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis Aripiprazole, Paliperidone - Schizophrenia, Treatment-resistant Schizophrenia | Phase 4 | Unknown | Consorcio Centro de Investigación Biomédica en Red (CIBER) | 244 | 2023-11-01 | 2023-09-29 |
| "Extended" (Alternate Day) Antipsychotic Dosing Risperidone, Olanzapine, paliperidone - Schizophrenia and Related Disorders, Drug Administration Schedule | Phase 4 | Recruiting | Centre for Addiction and Mental Health | 120 | 2022-06-06 | 2026-04-13 |
| Substance Misuse To Psychosis for Stimulants Aripiprazole, Paliperidone, Treatment as Usual - Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders | Phase 2 / Phase 3 | Completed | The University of Hong Kong | 165 | 2019-06-01 | 2026-03-27 |
| A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication ASP4345, placebo, risperidone - Schizophrenia | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 233 | 2018-07-13 | 2024-11-12 |
| A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment Paliperidone - Schizophrenia | Phase 1 / Phase 2 | Completed | Pharmathen S.A. | 70 | 2018-03-11 | 2019-07-19 |
| Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia Olanzapine, Paliperidone - Schizophrenia | Not applicable | Completed | Beijing HuiLongGuan Hospital | 100 | 2016-09-01 | 2018-01-18 |
| Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies Lithium Carbonate, Lamotrigine, Valproic Acid - Bipolar Disorder | Terminated | University of New Mexico | 1037352 | 2016-09-01 | 2024-03-12 | |
| Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone Aripiprazole, Olanzapine, Paliperidone - Immunoassay, Antipsychotic | Phase 1 | Completed | Janssen Research & Development, LLC | 81 | 2015-11-09 | 2025-08-15 |
| Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) Caregiver psycho-education and skills training, Caregiver support available at the study site, Paliperidone palmitate - Schizophrenia | Completed | Janssen Scientific Affairs, LLC | 296 | 2015-07-24 | 2019-01-23 | |
| A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry Aripiprazole, Olanzapine, Paliperidone - Schizophrenia, Schizoaffective Disorder | Phase 2 | Terminated | Janssen Research & Development, LLC | 9 | 2015-05-01 | 2017-03-29 |
| European Long-acting Antipsychotics in Schizophrenia Trial Aripiprazole, Aripiprazole depot, Paliperidone - Schizophrenia | Phase 4 | Completed | UMC Utrecht | 536 | 2015-02-01 | 2020-09-01 |
| Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features | Phase 4 | Completed | Technical University of Munich | 21 | 2015-02-01 | 2018-10-11 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study Paliperidone - Schizophrenia | Not applicable | Withdrawn | University of Maryland, Baltimore | 2014-01-01 | 2022-03-17 | |
| An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) Asenapine, Aripiprazole, Quetiapine - Bipolar Disorder | Completed | Organon and Co | 42 | 2013-04-01 | 2022-02-04 | |
| An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence Paliperidone, placebo - Methamphetamine Dependence | Not applicable | Completed | Wei Hao | 80 | 2013-02-01 | 2017-07-13 |
| A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis paliperidone, Risperidone - Methamphetamine Dependence | Phase 4 | Completed | Wei Hao | 120 | 2013-02-01 | 2015-02-04 |
| A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia Paliperidone extended-release, Risperidone immediate-release - Schizophrenia | Phase 4 | Terminated | Johnson & Johnson Taiwan Ltd | 17 | 2013-01-01 | 2016-04-13 |
| Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other | Phase 3 | Unknown | Fundación Pública Andaluza Progreso y Salud | 104 | 2012-11-01 | 2014-12-05 |
| Antipsychotics and Risk of Hyperglycemic Emergencies Olanzapine, Risperidone, atypical antipsychotics (other) - Psychotic Disorders, Schizophrenia | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 725489 | 2012-04-01 | 2015-10-21 |
Showing 20 of 40. Sign in to see all of them.
Schizophrenia (29) · Psychotic Disorders (6) · Bipolar Disorder (4) · Depression (3) · Diabetes Mellitus (2) · Anxiety Disorders (1) · Dementia (1) · Depressive Disorder, Major (1) · Diabetes Mellitus, Type 2 (1) · Disease (1) · Drug-Related Side Effects and Adverse Reactions (1) · Lipid Metabolism Disorders (1) · Non-alcoholic Fatty Liver Disease (1) · Obsessive-Compulsive Disorder (1) · Psychophysiologic Disorders (1)
Janssen Korea, Ltd., Korea (4) · Janssen Research & Development, LLC (4) · Janssen Scientific Affairs, LLC (2) · Wei Hao (2) · Astellas Pharma Global Development, Inc. (1) · Beijing HuiLongGuan Hospital (1) · Calo Psychiatric Center (1) · Canadian Network for Observational Drug Effect Studies, CNODES (1) · Centre for Addiction and Mental Health (1) · Consorcio Centro de Investigación Biomédica en Red (CIBER) (1) · Fundación Pública Andaluza Progreso y Salud (1) · Hannover Medical School (1) · Janssen Pharmaceutical K.K. (1) · Janssen-Cilag International NV (1) · Janssen-Cilag Pty Ltd (1)
United States (12) · South Korea (5) · China (4) · Germany (4) · Belgium (3) · Canada (2) · Israel (2) · Poland (2) · Romania (2) · Spain (2) · Austria (1) · Bulgaria (1) · Croatia (1) · Czechia (1) · Denmark (1)
Wei Hao, MD., Ph.D. (2) · Alexander Neumeister, MD (1) · Christophe G Lambert, PhD (1) · Eric A Storch, Ph.D. (1) · For-Wey Lung, MD, ScD (1) · Gary J Remington, MD, PhD (1) · Helge Frieling, Prof., MD (1) · Janet Wozniak, MD (1)
PMID 21155708, PMID 22516251, PMID 23842022, PMID 24581419, PMID 24870446, PMID 25375367, PMID 25938474, PMID 26403322, PMID 26742509, PMID 27574835, PMID 27627971, PMID 27629292, PMID 28901625, PMID 29920885, PMID 30509308, PMID 30986735, PMID 31237566, PMID 31651956, PMID 31744781, PMID 32296355, PMID 32533536, PMID 33688834, PMID 33988924, PMID 35436231, PMID 36716759, PMID 37756123, PMID 38958149, PMID 40932600, PMID 42656845
U01MH070007 (1), U01MH070008 (1), U01MH070009 (1), U01MH070010 (1), U01MH070011 (1), U01MH070012 (1), U01MH070016 (1), U01MH070017 (1), U01MH070023 (1)